✦ LIBER ✦

Increased adiponectin associated with poor survival in hepatocellular carcinoma

✍ Scribed by Wang, Shen-Nien; Yang, Sheau-Fang; Tsai, Hsin-Hui; Lee, King-Teh; Yeh, Yao-Tsung

Book ID: 125348993
Publisher: Springer Japan
Year: 2013
Tongue: English
Weight: 670 KB
Volume: 49
Category: Article
ISSN: 0944-1174
DOI: 10.1007/s00535-013-0898-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Growth arrest-specific homeobox is assoc

Growth arrest-specific homeobox is associated with poor survival in patients with hepatocellular carcinoma

✍ Peng Zhou, Zhi Chen, Rui-Min Chang, Wei Jiang, Lie-Lin Wu, Zhi-Ming Wang 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 340 KB

Expression of High Mobility GroupA2 is A

Expression of High Mobility GroupA2 is Associated with Poor Survival in Hepatocellular Carcinoma

✍ Lielin Wu, Zhiming Wang, Rongli Lu, Wei Jiang 📂 Article 📅 2012 🏛 Springer Netherlands 🌐 English ⚖ 300 KB

High expression of Golgi phosphoprotein-

High expression of Golgi phosphoprotein-3 is associated with poor survival in patients with hepatocellular carcinoma

✍ Hu, Guang-Sheng; Li, Ying-Qing; Yang, Yu-Ming; Shi, Wei; Liao, Ai-Jun; Yao, Yu-H 📂 Article 📅 2014 🏛 S. Karger AG 🌐 English ⚖ 861 KB

Poor association of GBV-C viremia with h

Poor association of GBV-C viremia with hepatocellular carcinoma

✍ Shoji Kubo; Shuhei Nishiguchi; Tetsuo Kuroki; Kazuhiro Hirohashi; Hiromu Tanaka; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 566 KB

665 SERUM ENDOSTATIN LEVEL IS ASSOCIATED

665 SERUM ENDOSTATIN LEVEL IS ASSOCIATED WITH POOR SURVIVAL IN PATIENTS WITH ADVANCED STAGES OF HEPATOCELLULAR CARCINOMA

✍ Yegin, E.; Syikymbayev, A.; Ozdogan, O.C. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Sirolimus-based immunosuppression is ass

Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma

✍ Christian Toso; Shaheed Merani; David L. Bigam; A.M. James Shapiro; Norman M. Kn 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB 👁 1 views

Liver transplantation is an important treatment option for selected patients with nonresectable hepatocellular carcinoma (HCC). Several reports have suggested a lower risk of posttransplant tumor recurrence with the use of sirolimus and a higher one with calcineurin inhibitors, but the selection of